Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Healthy Adult

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute for Neurodegenerative Disorders and XingImaging, LLC, New Haven, Connecticut, United States
Contact: Study coordinator (Stephanie Roman) · sroman@xingimaging.com · 475-318-8250
Contact: Principal Investigator (Neha Prakash, MBBS)

Study leads

Neha Prakash, MBBS
Principal Investigator
Institute for Neurodegenerative Disorders

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of V118E in Healthy Participants (V118E-003)

Healthy

Abroad (travel likely)RecruitingPHASE1

Hallandale, United States · South Miami, United States

A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

Healthy Volunteer Study · Healthy Adults · Healthy Participants

Abroad (travel likely)RecruitingPHASE1

New Haven, United States

To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers

Healthy

Abroad (travel likely)RecruitingPHASE1

Seoul, South Korea

Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and Multiple Administration

Chinese Healthy Adult Subjects

Abroad (travel likely)RecruitingPHASE1

Jinan, China